Repeated sequences in CASPASE-5 and FANCD2 but not NF1 are targets for mutation in microsatellite-unstable acute leukemia/myelodysplastic syndrome

Molecular Cancer Research

Volumn 3, Issue 5, 2005, Pages 251-260

  Offman, Judith ^a   Gascoigne, Karen ^a   Bristow, Fiona ^a   Macpherson, Peter ^a   Bignami, Margherita ^b   Casorelli, Ida ^b   Leone, Giuseppe ^c   Pagano, Livio ^c   Sica, Simona ^c   Halil, Ozay ^d   Cummins, David ^d   Banner, Nicholas R ^d   Karran, Peter ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c CATHOLIC UNIVERSITY   (Italy)

^d HAREFIELD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 5; GENOMIC DNA;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LEUKEMIA; ARTICLE; CANCER CHEMOTHERAPY; COLORECTAL CARCINOMA; DNA POLYMORPHISM; ENDOMETRIUM CARCINOMA; FANCONI ANEMIA COMPLEMENTATION GROUP D2 GENE; FRAMESHIFT MUTATION; GASTROINTESTINAL TUMOR; GENE; GENE TARGETING; HUMAN; HUMAN CELL; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; MUTATION; MYELODYSPLASTIC SYNDROME; NEUROFIBROMATOSIS TYPE 1 GENE; NUCLEOTIDE REPEAT; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

ALLELES; CASPASES; CELL LINE, TUMOR; GENOTYPE; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; MICROSATELLITE REPEATS; MUTAGENESIS; MYELODYSPLASTIC SYNDROMES; NEUROFIBROMIN 1;

EID: 20844434652     PISSN: 15417786     EISSN: None     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-04-0182     Document Type: Article

References (38)

1. Peltomäki P. Role of DNA mismatch repair defects in the pathogenesis of human cancer. J Clin Oncol 2003;21:1174-9.
2. Jiricny J, Nyström-Lahti M. Mismatch repair defects in cancer. Curr Opin Genet Dev 2000;10:157-61.
3. Ionov Y, Peinado MA, Malkhosyan S, Shibata D, Perucho M. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 1993;363:558-61.
4. Aaltonen LA, Peltomäki P, Leach FS, et al. Clues to the pathogenesis of familial colorectal cancer. Science 1993;260:812-6.
5. Lengauer C, Kinzler KW, Vogelstein B. Genetic instability in colorectal cancers. Nature 1997;386:623-6.
6. Markowitz S, Wang J, Myerhoff L, et al. Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science 1995;268:1336-8.
7. Rampino N, Yamamoto H, Ionov Y, et al. Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype. Science 1997;275:967-9.
8. Kim N-G, Choi YR, Baek MJ, et al. Frameshift mutations at coding mononucleotide repeats of the hRAD50 gene in gastrointestinal carcinomas with microsatellite instability. Cancer Res 2000;61:36-8.
9. Giannini G, Ristori E, Cerignoli F, et al. Human MRE11 is inactivated in mismatch repair-deficient cancers. EMBO Rep 2002;3:248-54.
10. Bignami M, Casorelli I, Karran P. Mismatch repair and response to DNA-damaging antitumor therapies. Eur J Cancer 2003;39:2142-9.
11. Ben-Yehuda D, Krichevsky S, Caspi O, et al. Microsatellite instability and p53 mutations in therapy-related leukemia suggest mutator phenotype. Blood 1996;88:4296-303.
12. Das-Gupta EP, Seedhouse CH, Russell NH. Microsatellite instability occurs in defined subsets of patients with acute myeloblastic leukaemia. Br J Haematol 2001;114:307-12.
13. Sheikhha MH, Tobal K, Yin JAL. High level of microsatellite instability but not hypermethylation of mismatch repair genes in therapy-related and secondary acute myeloid leukaemia and myelodysplastic syndrome. Br J Haematol 2002;117:359-65.
14. Casorelli I, Offman J, Mele L, et al. Drug treatment in the development of mismatch repair defective acute leukemia and myelodysplastic syndrome. DNA Repair 2003;2:547-59.
15. Offman J, Opelz G, Doehler B, et al. Defective DNA mismatch repair in acute myeloid leukemia/myelodysplastic syndrome after organ transplantation. Blood 2004;104:822-8.
16. Karran P, Offman J, Bignami M. Human mismatch repair, drug-induced DNA damage, and secondary cancer. Biochimie 2003;85:1149-60.
17. Faulkner RD, Seedhouse CH, Das-Gupta EP, Russell NH. BAT-25 and BAT-26, two mononucleotide microsatellites, are not sensitive markers of microsatellite instability in acute myeloid leukaemia. Br J Haematol 2004;124:160-5.
18. Garcia-Higuera I, Taniguchi T, Ganesan S, et al. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Mol Cell 2001;7:249-62.
19. Abdel-Rahman WM, Arends MJ, Wyllie AH, Morris RG, Ramadan ME. Death pathway genes Fas (Apo-1/CD95) and Bik (Nbk) show no mutations in colorectal carcinomas. Cell Death Differ 1999;6:387-8.
20. Yamamoto H, Gil J, Schwartz S, Perucho M. Frameshift mutations in Fas, Apaf-1, and Bel-10 in gastro-intestinal cancer of the microsatellite mutator phenotype. Cell Death Differ 2000;7:238-9.
21. Schwartz S, Yamamoto H, Navarro M, Maestro M, Reventos J, Perucho M. Frameshift mutations at mononucleotide repeats in caspase-5 and other target genes in endometrial and gastrointestinal cancer of the microsatellite mutator phenotype. Cancer Res 1999;59:2995-3002.
22. Takeuchi S, Takeuchi N, Fermin AC, Taguchi H, Koeffler HP. Frameshift mutations in caspase-5 and other target genes in leukemia and lymphoma cell lines having microsatellite instability. Leuk Res 2003;27:359-61.
23. Scott S, Kimura T, Ichinohasama R, et al. Microsatellite mutations of transforming growth factor-b receptor type II and caspase-5 occur in human precursor T-cell lymphoblastic lymphomas/leukemias in vivo but are not associated with hMSH2 or hMLH1 promoter methylation. Leuk Res 2003;27:23-34.
24. Olipitz W, Hopfinger G, Aguiar RCT, et al. Defective DNA mismatch repair: a potential mediator of leukemogenic susceptibility in therapy-related myelodysplasia and leukemia. Genes Chromosomes Cancer 2002;34:243-8.
25. Martinon M, Tschopp J. Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases. Cell 2004;117:561-74.
26. Dasgupta B, Gutmann DH. Neurofibromatosis 1: closing the GAP between mice and men. Curr Opin Genet Dev 2003;13:20-7.
27. Mahgoub N, Taylor BR, Beau MML, et al. Myeloid malignancies induced by alkylating agents in Nf1 mice. Blood 1999;93:3617-23.
28. Ricciardone MD, Ozcelik T, Cevher B, et al. Human MLH1 deficiency predisposes to hematological malignancy and neurofibromatosis type 1. Cancer Res 1999;59:290-3.
29. Whiteside D, McLeod R, Graham G, et al. A homozygous germ-line mutation in the human MSH2 gene predisposes to hematological malignancy and multiple cafe-au-lait spots. Cancer Res 2002;62:359-62.
30. Gallinger S, Aronson M, Shayan K, et al. Gastrointestinal cancers and neurofibromatosis type 1 features in children with a germline homozygous MLH1 mutation. Gastroenterology 2004;126:576-85.
31. Wang Q, Montmain G, Ruano E, et al. Neurofibromatosis type 1 gene as a mutational target in a mismatch repair-deficient cell type. Hum Genet 2003;112:117-23.
32. Gutmann DH, Winkeler E, Kabbarath O, et al. Mlh1 deficiency accelerates myeloid leukemogenesis in neurofibromatosis 1 (Nf1) heterozygous mice. Oncogene 2003;22:4581-5.
33. D'Andrea AD, Grompe M. The Fanconi anemia/BRCA pathway. Nat Rev Cancer 2002;3:23-34.
34. Alter BP. Cancer in Fanconi anemia, 1927-2001. Cancer 2003;97:425-40.
35. Thurston VC, Ceperich TM, Vance GH, Heerema NA. Detection of monosomy 7 in bone marrow by fluorescence in situ hybridization. A study of Fanconi anemia patients and review of the literature. Cancer Genet Cytogenet 1999;109:154-60.
36. Alter BP, Caruso JP, Drachtman RA, Uchida T, Velagaleti GVN, Eleghetany MT. Fanconi anemia: myelodysplasia as a predictor of outcome. Cancer Genet Cytogenet 2000;117:125-31.
37. Branch P, Masson M, Aquilina G, Bignami M, Karran P. Spontaneous development of drug resistance: mismatch repair and p53 defects in resistance to cisplatin in human tumor cells. Oncogene 2000;19:3138-45.
38. Branch P, Aquilina G, Bignami M, Karran P. Defective mismatch binding and a mutator phenotype in cells tolerant to DNA damage. Nature 1993;362:652-4.